Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.

Rodríguez-Pérez JC, García-Bello MA, Anabitarte-Prieto A, Companioni O, Nóvoa-Mogollón FJ, Suárez-Ortega S, Plaza-Toledano C, Rodríguez-Esparragón F.

Clin Exp Hypertens. 2011;33(8):506-10. doi: 10.3109/10641963.2011.561900. Epub 2011 Sep 29.

PMID:
21958392
2.

Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.

Rysavá R, Tesar V, Merta M; Czech Group for the Study of Glomerulonephritis.

Blood Press Monit. 2005 Aug;10(4):207-13.

PMID:
16077267
3.

Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.

Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S; INNOVATION Study Group.

Hypertens Res. 2008 Apr;31(4):657-64. doi: 10.1291/hypres.31.657.

PMID:
18633177
4.

Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.

Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.

Eur Rev Med Pharmacol Sci. 2012 Apr;16(4):491-8.

PMID:
22696876
5.

Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).

Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S.

Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9.

PMID:
22571446
6.

Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.

Kojima M, Ohashi M, Dohi Y, Kimura G.

J Hypertens. 2013 Jan;31(1):186-91. doi: 10.1097/HJH.0b013e32835a2724.

PMID:
23047595
8.

Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.

Neldam S, Edwards C, Jones R; TEAMSTA-10 Investigators.

Curr Med Res Opin. 2011 Nov;27(11):2145-53. doi: 10.1185/03007995.2011.624089. Epub 2011 Sep 29.

PMID:
21955225
9.

Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.

Littlejohn TW 3rd, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, Oigman W; study investigators.

Postgrad Med. 2009 Mar;121(2):5-14. doi: 10.3810/pgm.2009.03.1972.

PMID:
19332958
10.

Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.

Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C; VIVALDI investigators.

Nephrol Dial Transplant. 2008 Oct;23(10):3174-83. doi: 10.1093/ndt/gfn230. Epub 2008 May 1.

11.

Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.

Guthrie RM.

Postgrad Med. 2011 Nov;123(6):58-65. doi: 10.3810/pgm.2011.11.2495. Review.

PMID:
22104454
12.

Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.

Weinbergová O, Metelka R, Vymetal J, Konecný K, Kosatíková Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004 Jul;148(1):69-73.

13.

Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.

Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):137-42. doi: 10.2165/11598110-000000000-00000.

PMID:
22329591
14.

Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients.

Ishimitsu T, Kobayashi T, Honda T, Takahashi M, Minami J, Ohta S, Inada H, Yoshii M, Ono H, Matsuoka H.

Hypertens Res. 2005 Apr;28(4):351-9.

PMID:
16138566
15.

Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate.

Nakagawa N, Fujino T, Kabara M, Matsuki M, Chinda J, Kikuchi K, Hasebe N; NICE-Combi Study Group.

Hypertens Res. 2011 Oct;34(10):1121-6. doi: 10.1038/hr.2011.101. Epub 2011 Jul 28.

PMID:
21796123
16.

Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.

White WB, Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Schumacher H, Mancia G.

Blood Press Monit. 2010 Aug;15(4):205-12. doi: 10.1097/MBP.0b013e32833c5722.

PMID:
20613496
17.
18.
19.

Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.

Sharma AM, Hollander A, Köster J; Efficacy and Safety in Patients with Renal Impairment; treated with Telmisartan (ESPRIT) Study Group.

Clin Nephrol. 2005 Apr;63(4):250-7.

PMID:
15847251
20.

Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.

Sengul AM, Altuntas Y, Kürklü A, Aydin L.

Diabetes Res Clin Pract. 2006 Feb;71(2):210-9. Epub 2005 Aug 19.

PMID:
16112244
Items per page

Supplemental Content

Write to the Help Desk